Auris Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Auris Medical and buy or sell other stocks, ETFs, and their options commission-free!

About EARS

Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. 

CEO
Thomas Meyer, PhD
CEOThomas Meyer, PhD
Employees
Employees
Headquarters
Hamilton, Hamilton
HeadquartersHamilton, Hamilton
Founded
2003
Founded2003
Employees
Employees

EARS Key Statistics

Market cap
18.35M
Market cap18.35M
Price-Earnings ratio
-0.13
Price-Earnings ratio-0.13
Dividend yield
Dividend yield
Average volume
340.90
Average volume340.90
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.1478
52 Week high$0.1478
52 Week low
$0.0497
52 Week low$0.0497

Stock Snapshot

With a market cap of 18.35M, Auris Medical(EARS) trades at $3.21. The stock has a price-to-earnings ratio of -0.13.

During the trading day, Auris Medical(EARS) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Auris Medical(EARS) stock has reached 0, versus its average volume of 340.9.

The stock's 52-week range extends from a low of $0.05 to a high of $0.15.

The stock's 52-week range extends from a low of $0.05 to a high of $0.15.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.